Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
PLoS One. 2013;8(2):e55175. doi: 10.1371/journal.pone.0055175. Epub 2013 Feb 7.
Activation of blood coagulation and fibrinolysis may be associated with increased risk of coronary heart disease. We aimed to assess associations of circulating tissue plasminogen activator (t-PA) antigen, D-dimer and von Willebrand factor (VWF) with coronary heart disease risk.
Prospective case-control study, systematic review and meta-analyses.
Measurements were made in 1925 people who had a first-ever nonfatal myocardial infarction or died of coronary heart disease during follow-up (median 19.4 years) and in 3616 controls nested within the prospective population-based Reykjavik Study.
Age and sex-adjusted odds ratios for coronary heart disease per 1 standard deviation higher baseline level were 1.25 (1.18, 1.33) for t-PA antigen, 1.01 (0.95, 1.07) for D-dimer and 1.11 (1.05, 1.18) for VWF. After additional adjustment for conventional cardiovascular risk factors, corresponding odds ratios were 1.07 (0.99, 1.14) for t-PA antigen, 1.06 (1.00, 1.13) for D-dimer and 1.08 (1.02, 1.15) for VWF. When combined with the results from previous prospective studies in a random-effects meta-analysis, overall adjusted odds ratios were 1.13 (1.06, 1.21) for t-PA antigen (13 studies, 5494 cases), 1.23 (1.16, 1.32) with D-dimer (18 studies, 6799 cases) and 1.16 (1.10, 1.22) with VWF (15 studies, 6556 cases).
Concentrations of t-PA antigen, D-dimer and VWF may be more modestly associated with first-ever CHD events than previously reported. More detailed analysis is required to clarify whether these markers are causal risk factors or simply correlates of coronary heart disease.
血液凝固和纤维蛋白溶解的激活可能与冠心病风险增加有关。我们旨在评估循环组织型纤溶酶原激活物(t-PA)抗原、D-二聚体和血管性血友病因子(VWF)与冠心病风险的关系。
前瞻性病例对照研究、系统评价和荟萃分析。
在首次非致命性心肌梗死或随访期间死于冠心病的 1925 名患者(中位随访时间 19.4 年)和前瞻性人群为基础的雷克雅未克研究中嵌套的 3616 名对照者中进行了测量。
按年龄和性别调整的冠心病每 1 个标准差基线水平的优势比为 t-PA 抗原 1.25(1.18,1.33)、D-二聚体 1.01(0.95,1.07)和 VWF 1.11(1.05,1.18)。在进一步调整传统心血管危险因素后,相应的优势比为 t-PA 抗原 1.07(0.99,1.14)、D-二聚体 1.06(1.00,1.13)和 VWF 1.08(1.02,1.15)。当将随机效应荟萃分析中以前的前瞻性研究结果结合起来时,总体调整后的优势比为 t-PA 抗原 1.13(1.06,1.21)(13 项研究,5494 例),D-二聚体 1.23(1.16,1.32)(18 项研究,6799 例)和 VWF 1.16(1.10,1.22)(15 项研究,6556 例)。
t-PA 抗原、D-二聚体和 VWF 的浓度与首次 CHD 事件的相关性可能比以前报道的更为温和。需要更详细的分析来澄清这些标志物是因果危险因素还是冠心病的简单相关因素。